Guidelines Update Methodology 在更新该版NCCN乳腺癌指南之前,采用以下检索词进行电子检索获取乳腺癌关键文献:乳腺癌、乳腺肿瘤、导管原位癌、炎性乳腺癌、或叶状乳腺癌。 Prior to the updateof this version of the NCCN Guidelines for Breast Cancer, an electronic search of the PubMed database was performed t...
[5]Primary results from TROPiCS-02: A randomized phase 3 study of sacituzumab govitecan (SG) versus treatment of physician’s choice (TPC) in patients (Pts) with hormone receptor–positive/HER2-negative (HR+/HER2-) advanced breast cancer. | Journal of Clinical Oncology https://ascopubs.org...
Imaging, 3rd bullet added:For patients with germline mutations or family history of breast cancer, please refer to See NCCN Guidelines for Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic 新增:治疗后监测 Added:Post treatment monitoring 新增...
Bullet 4 revised:Patients should be advised not to become pregnant while on any systemic therapy and specific drug package inserts should be consulted for recommendations.Patients should not become pregnant during treatment with RT, chemotherapy, endocrine therap...
[5]Primary results from TROPiCS-02: A randomized phase 3 study of sacituzumab govitecan (SG) versus treatment of physician’s choice (TPC) in patients (Pts) with hormone receptor–positive/HER2-negative (HR+/HER2-) advanced breast cancer. | Journal of Clinical Oncology ...
Guidelines Update Methodology 在更新该版NCCN乳腺癌指南之前,采用以下检索词进行电子检索获取乳腺癌关键文献:乳腺癌、乳腺肿瘤、导管原位癌、炎性乳腺癌、或叶状乳腺癌。 Prior to the update of this version of the NCCN Guidelines for Breast Cancer, an electronic search of the PubMed database was performed...
Imaging, 3rd bullet added:For patients with germline mutations or family history of breast cancer, please refer to See NCCN Guidelines for Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic 新增:治疗后监测 Added:Post treatment monitoring ...
for Breast Cancer Screening and Diagnosis Cancers and DCIS (BINV-F) Participation in clinical trials is Noninvasive Breast Cancer Special Considerations to Breast Conservation Therapy especially encouraged. D uctal Carcinoma In Situ (DCIS) Workup and Primary Treatment Requiring RT (BINV-G) Find an...
Systemic Adjuvant Treatment, Postmenopausal, new node added:pT1-3 AND pN0 or pN+ 删除脚注x:不伴相关常见浸润的包裹性乳头状癌被定为病理Tis期,因为其行为与导管原位癌相似(根据美国癌症联合委员会分期标准)。根据世界卫生组织标准,应说明实体性乳头状癌是原位还是浸润,但是两种形式都有良好的结局。(也适用于...
[9]Kalinsky K, Spring L, Yam C, et al. Real-world use patterns, effectiveness, and tolerability of sacituzumab govitecan for second-line and later-line treatment of metastatic triple-negative breast cancer in the United States.Breast Cancer Res Treat. Published online June 21, 2024....